1. Home
  2. ZURA vs TREE Comparison

ZURA vs TREE Comparison

Compare ZURA & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$3.96

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Logo LendingTree Inc.

TREE

LendingTree Inc.

N/A

Current Price

$27.90

Market Cap

393.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
TREE
Founded
2022
1996
Country
United States
United States
Employees
N/A
926
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
393.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
ZURA
TREE
Price
$3.96
$27.90
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$19.00
★ $56.00
AVG Volume (30 Days)
★ 4.7M
230.7K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 443.31
EPS
N/A
★ 1.90
Revenue
N/A
★ $1,117,324,000.00
Revenue This Year
N/A
$17.25
Revenue Next Year
N/A
$6.95
P/E Ratio
★ N/A
$14.71
Revenue Growth
N/A
★ 24.12
52 Week Low
$3.25
$23.50
52 Week High
$7.25
$68.93

Technical Indicators

Market Signals
Indicator
ZURA
TREE
Relative Strength Index (RSI) 46.57 60.22
Support Level $3.26 $23.51
Resistance Level $6.05 $39.74
Average True Range (ATR) 0.53 1.05
MACD 0.05 0.37
Stochastic Oscillator 45.70 91.19

Price Performance

Historical Comparison
ZURA
TREE

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

Share on Social Networks: